Regencell Bioscience Holdings RGC
NASDAQ RGC
$10.80 +0.35 (+3.35%)
At close: Oct 21, 2026 · 4:00 PM EDT

Regencell Bioscience Holdings (RGC) Enterprise Value (2022 - 2026)

Updated

Regencell Bioscience Holdings (RGC) recorded Enterprise Value of $65.06 million in the quarter ended Jun 30, 2026, down 70.0% from $216.84 million a year earlier.

Analysis

Regencell Bioscience Holdings (RGC) Enterprise Value (2022 - 2026) Analysis & Trends

Starting with the quarter ended Jun 30, 2022, Regencell Bioscience Holdings' Enterprise Value history includes 6 quarters.

  • Across earlier years, Enterprise Value came in at $216.84 million in the year ended Jun 30, 2025, -$6.79 million in the year ended Jun 30, 2024, $16.33 million in the year ended Jun 30, 2023 and -$4.56 million in the year ended Jun 30, 2022.
  • The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Enterprise Value since the quarter ended Jun 30, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Regencell Bioscience Holdings 5.36 Bn 5.33 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.01 Bn
Dec 31, 2025 10.38 Bn
Jun 30, 2025 8.42 Bn
Jun 30, 2024 -6.79 Mn
Jun 30, 2023 -3.67 Mn
Jun 30, 2022 -4.56 Mn
API Access

Regencell Bioscience Holdings Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=RGC&period=max&api_key=YOUR_API_KEY